Compare drug alternatives
Aimovig® Alternatives
Aimovig®
(Erenumab)
Aimovig
-
Migraine
- Emgality®
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig.
Aimovig is FDA approved for the following indications: Migraine prevention.
Qulipta®
(Atogepant)
Qulipta
-
Migraine
- Emgality®
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation.
Qulipta is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Subcutaneous
Oral
Dosing
70 mg once monthly or 140 mg once monthly (for some patients)
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
Latin Shorthand
70 mg/mo or 140 mg/mo
10mg qd, 30mg qd or 60mg qd
Renal Impairment: 10mg qd
Financial Assistance
Copay
$5
$0
Annual Cap
Patient specific maximum benefit.
$6,000
Assistance Expiration
Calendar year
12 30-day prescription fills
Generics
No lower-cost generic available
No lower-cost generic available